Pre-Conference Seminar Day
Tuesday, 12th March, 2024

Introduction to ADCs Day

Introduction to ADCs Day

Chair: John Lambert, Independent Consultant, Attager Consulting

Download the Full Event Guide for full details


The morning session will cover: 

  • Gaining familiarity with the fundamental early learnings that inform ADC design
  • Learning about the key insights that allowed early investigators to overcome the initial challenges that hindered early ADC programmes
  • Providing an understanding of the biological aspects of ADCs
  • Selecting the most appropriate ADC target
  • Choosing an optimum antibody format

12:00 Lunch & Networking


The afternoon session will cover: 

  • Evaluating payload choices for ADCs
  • Reviewing linker design chemistry and what it can bring
  • Understanding the impact of conjugation site selection on ADCs
  • Analysing the choices and trade-offs in utilising the chemistry ADC toolbox
  • Assessing key factors in the evaluation of efficacy information from in vivo preclinical models

3:00 Session End

2nd Next-Generation Conjugates Day
1st Toxicity Day
2nd ADCs in Combination Day
4th CMC Day

3:00 pm Technology Partnerships Evening

Synopsis

This brand-new networking experience will facilitate conversations between companies looking to partner and collaborate with those developing innovative technologies. Aimed at large pharma, established ADC biotechs, and novel companies disrupting the ADC norm with breakthrough linker-payload, conjugation, or antibody technologies, this session will allow you to connect with potential partners whom can harness one another’s technologies to move the dial forward of ADC design. This session is perfect for those working in licensing, business development, C-level executives, or technology leads, to offer a melting pot of scientific and strategic dialogues.